Cargando…

Clinical Signifčcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients

BACKGROUND: Angiogenesis plays an essential role in tumor growth and serum levels of YKL-40, a strong angiogenic factor that promotes tumor vessel development, has been found to be elevated in various cancers. We here investigated correlation between melanoma parameters and serum YKL-40 levels, to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erturk, Kayhan, Tas, Faruk, Serilmez, Murat, Bilgin, Elif, Yasasever, Vildan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555551/ https://www.ncbi.nlm.nih.gov/pubmed/28612591 http://dx.doi.org/10.22034/APJCP.2017.18.5.1383

Ejemplares similares

Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma
por: Tas, Faruk, et al.
Publicado: (2017)

Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients
por: Tas, Faruk, et al.
Publicado: (2017)

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma
por: Tas, Faruk, et al.
Publicado: (2016)

Widespread finger skin metastases of melanoma
por: Tas, Faruk, et al.
Publicado: (2018)

The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung Disease
por: Hector, Andreas, et al.
Publicado: (2011)

Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis
por: Salomon, Joanna, et al.
Publicado: (2017)

Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis
por: Salomon, Joanna, et al.
Publicado: (2017)

Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem Cells
por: Hoover, Daniel J., et al.
Publicado: (2013)

Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations
por: Liu, Lei, et al.
Publicado: (2019)

Chitinase-3-like Protein 1 (YKL-40): A New Biomarker of Inflammation in Pyoderma Gangrenosum
por: JANKOWSKA-KONSUR, Alina, et al.
Publicado: (2022)

Correction: Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem Cells
Publicado: (2014)

Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis
por: Salomon, Joanna, et al.
Publicado: (2018)

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
por: Querol-Vilaseca, Marta, et al.
Publicado: (2017)

Overexpression of Chitinase 3-Like 1/YKL-40 in Lung-Specific IL-18-Transgenic Mice, Smokers and COPD
por: Sakazaki, Yuki, et al.
Publicado: (2011)

Increased Plasma YKL-40/Chitinase-3-Like-Protein-1 Is Associated with Endothelial Dysfunction in Obstructive Sleep Apnea
por: Jafari, Behrouz, et al.
Publicado: (2014)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer
por: Bademler, Suleyman, et al.
Publicado: (2019)

Correction: Increased Plasma YKL-40/Chitinase-3-Like-Protein-1 Is Associated with Endothelial Dysfunction in Obstructive Sleep Apnea
Publicado: (2014)

Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40
por: Deming, Yuetiva, et al.
Publicado: (2016)

Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects
por: Nielsen, Kaspar R, et al.
Publicado: (2011)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer
por: Afsar, Cigdem Usul, et al.
Publicado: (2018)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014)

Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
por: Jafari-Nakhjavani, Mohammad Reza, et al.
Publicado: (2019)

Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children
por: Kwon, Yoowon, et al.
Publicado: (2020)

Quantitative Real-Time PCR Analysis of YKL-40 and Its Comparison with Mammalian Chitinase mRNAs in Normal Human Tissues Using a Single Standard DNA
por: Ohno, Misa, et al.
Publicado: (2015)

Plasma Levels of the Proinflammatory Chitin‐Binding Glycoprotein YKL‐40, Variation in the Chitinase 3‐Like 1 Gene (CHI3L1), and Incident Cardiovascular Events
por: Ridker, Paul M, et al.
Publicado: (2014)

Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma
por: Karabulut, Senem, et al.
Publicado: (2016)

Serum YKL-40 Levels and Chitotriosidase Activity in Patients with Beta-Thalassemia Major
por: Musumeci, Maria, et al.
Publicado: (2014)

Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome
por: Akboğa, Mehmet Kadri, et al.
Publicado: (2016)

Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)

Serum YKL-40 Levels, Leukocyte Profiles, and Acute Exacerbations of Advanced COPD
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_12o9n1b8f8iutpbkj9bkdl6jb0